Ir al menú
Ir al contenido principal
Instituto Ramón y Cajal de investigación sanitaria
Personal researcher access
Donations
ESP
ENG
Search
Searcher
Search
Menu
IRYCIS
Presentation
Structure and organization
Foundation
Documentation
Corporative Scientific Reports
RRI
Research
Innovation
Services
Central Support Units
Animal facility and experimental surgery
Aptamers
Biobank and biomodels
Clinical biostatistics
Biomarkers and therapeutic targets
Lipidomics and proteomics characterization (UCA-CLP)
Data Science
Clinical studies and phase II-IV trials
Translational Genomics (NGS) and Bioinformatics
Microscopy, histology and comparative pathology
Clinical Research and Clinical Trials Unit & Early Phase Clinical Trials Unit
Other service and technical units
Single cell analysis: spectral cytometry
Radiological image analysis and process engineering
Gas chromatography coupled to mass spectrometry
Scientific and Technical Service of Cell Cultures
Photobiology and Bioelectromagnetism
Precision immunological markers
Microarrays
Chromatographic services and CNS markers
Facilities of IRYCIS universities
Calls
Training
Communication
Personal researcher access
Donations
ESP
ENG
Searcher
Search
← Other entries
IMI / IHI
COMBACTE-CARE
Combatting bacterial resistence in EuropeCarbapenem Resistence
Related Links
https://www.irycis.org/es/comunicacion/noticias/180/continua-y-exitosa-participacion-de-grupos-del-area-2-del-irycis-en-dos-grandes-consorcios-europeos-imi-combacte
Related Links
https://www.irycis.org/es/comunicacion/noticias/180/continua-y-exitosa-participacion-de-grupos-del-area-2-del-irycis-en-dos-grandes-consorcios-europeos-imi-combacte
Share
Instituto Ramón y Cajal de investigación sanitaria